← Open Payments lookup

PAUL GAMBINO: Open Payments

NPI 1235427451 · STUART, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$36,990 in 163 payments from 27 companies in 2025. Trend: 2023 $67,963 · 2024 $40,596 · 2025 $36,990

Speaker / faculty: $32,800Food & beverage: $2,782Travel & lodging: $1,408
CompanyPaymentsAmount
Amgen Inc.59$34,904
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)19$325
Novartis Pharmaceuticals Corporation10$207
AstraZeneca Pharmaceuticals LP9$192
PFIZER INC.9$179
Novo Nordisk Inc11$160
GlaxoSmithKline, LLC.5$107
ABBVIE INC.5$104
Lilly USA, LLC4$91
Janssen Pharmaceuticals, Inc3$91

Products named: REPATHA, CAPLYTA, LEQVIO, OTEZLA, NURTEC ODT, AIRSUPRA, TRELEGY ELLIPTA, SPRAVATO.

Industry payments across FL — which companies pay providers there.